Edwards Lifesciences (XSWX:EW) Unearned Premiums

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:EW Edwards Lifesciences Corp XSWX:EW
98 GF Score
Price CHF74.11
GF Value CHF76.30
! 5 Warning Signs
View Full Analysis

What is Edwards Lifesciences Unearned Premiums?

Unearned Premiums only applies to insurance companies.

XSWX:EW
98GF Score
Edwards Lifesciences Corp XSWX:EW
Unearned Premiums is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Edwards Lifesciences (XSWX:EW) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued. The current stock price of CHF74.11 is trading 2.9% below its estimated GF Value™ of CHF76.30.

Key valuation signals for XSWX:EW:

  • Unearned Premiums:
  • GF Value™: CHF76.30 vs. price of CHF74.11 (2.9% below fair value)
  • GF Score™: 98/100 with 5 warning signs

No single metric tells the full story. See the XSWX:EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Edwards Lifesciences Business Description

Address One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
98GF Score

Get the complete analysis for XSWX:EW

Unearned Premiums is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.11
Price
CHF76.30
GF Value